Abstract
High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy: association with dendritic cell growth activity.
Amiel Tokayer, Steven E Carsons, Binny Chokshi and Frances Santiago-Schwarz
The Journal of Rheumatology March 2002, 29 (3) 454-461;
Amiel Tokayer
Steven E Carsons
Binny Chokshi
Frances Santiago-Schwarz
In this issue
High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy: association with dendritic cell growth activity.
Amiel Tokayer, Steven E Carsons, Binny Chokshi, Frances Santiago-Schwarz
The Journal of Rheumatology Mar 2002, 29 (3) 454-461;